Genhui Chen
President chez Beijing Wenfeng Medical Technology Ltd.
Profil
Genhui Chen is currently the President of Beijing Wenfeng Medical Technology Ltd.
He previously served as the President & Chief Executive Officer of Welichem Biotech, Inc. from 1995 to 2009.
From 2013 to 2016, he was an Independent Director at Lianluo Smart Ltd.
Chen received a graduate degree from Simon Fraser University in 1988 and a doctorate degree from the same institution in 1991.
Postes actifs de Genhui Chen
| Sociétés | Poste | Début |
|---|---|---|
| Beijing Wenfeng Medical Technology Ltd. | President | - |
Anciens postes connus de Genhui Chen
| Sociétés | Poste | Fin |
|---|---|---|
| NEWEGG COMMERCE, INC. | Directeur/Membre du Conseil | 25/10/2016 |
Welichem Biotech, Inc.
 Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | President | 17/11/2009 |
Formation de Genhui Chen
| Simon Fraser University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
Lianluo Smart Ltd.
 Lianluo Smart Ltd. Medical SpecialtiesHealth Technology Lianluo Smart Ltd. engages in the development and marketing of medical wearable devices, smart devices and ecosystem platform. The medical wearable sector focuses on wearable sleep respiratory devices, focusing primarily on sleep respiratory solutions to obstructive sleep apnea syndrome. The smart devices sector is specialized in operating easy-use smart devices for sports, social contact, entertainment, remote-control and family health management, which can connect things and humans in an intelligent way. The smart ecosystem platform sector, intends to build an ecosystem to facilitate interconnection among smart products and between smart products and users. The company was founded by Ping Chen on July 22, 2003 and is headquartered in Beijing, China. | Health Technology |
| Beijing Wenfeng Medical Technology Ltd. |